Sherene Mason, MD, MBA

Division Head, Nephrology | Medical Director, Dialysis and Pheresis | Robert R. Rosenheim Endowed Chair for Nephrology

Sherene Mason, MD, MBA, is Division Head of Nephrology and Medical Director of Dialysis and Pheresis. She has a strong interest in congenital abnormalities of the kidney and urinary tract, mechanisms underlying acute and chronic kidney disease, and renal transplantation.  She is a member of several professional organizations, including the American Society of Pediatric Nephrology, the American Academy of Pediatrics, and the American Society of Nephrology. Dr. Mason completed her pediatric residency, a year as Chief Resident, and a fellowship in Pediatric Nephrology at Yale University School of Medicine. During her fellowship, Dr. Mason completed research examining pathways important in renal tubular repair following renal injury. She was awarded the American Society of Pediatric Nephrology Fellow’s Research Award in Basic Science for her work.

Education

University of Connecticut School of Medicine

Residency

Yale-New Haven Children's Hospital

Fellowship

Children's Hospital at Yale-New Haven Hospital

American Board of Pediatrics- Pediatric Nephrology
American Board of Pediatrics- General Pediatrics

Assistant Professor of Pediatrics, University of Connecticut School of Medicine

  • Misurac JM, Grinsell MM, Hansen Narus J, Mason S, Kallash M, Andreoli SP. NSAID-Associated acute kidney injury in Hospitalized Children – A Prospective Pediatric Nephrology Research Consortium Study. Pediatr Nephrol. 2023 March 21; doi: 10.1007/s00467-023-05916-y
  • Soliman S, Haque A, Vanarsa K, Zhang T, Ismail F, Lee KH, Pedroza C, Greenbaum LA, Mason S, Hicks J, Wenderfer S, Mohan C. Urine ALCAM, PF4 and VCAM-1 surpass conventional metrics in identifying nephritis disease activity in childhood-onset systemic lupus erythematosus. Front. Immunol. 2022 May; 13 doi: 10.3389/fimmu.2022.885307.
  • Wenderfer S., Mason S., Bernal C., da Silva C.A.A. Lupus Nephritis. In: Emma F., Goldstein S., Bagga A., Bates C.M., Shroff R. (editors). Pediatric Nephrology. 8th Ed. 2022 Edition. Springer, Berlin, Heidelberg
  • Soliman S, Haque A, Mason S, Greenbaum L, Hicks MJ, Mohan C, Wenderfer S. Cross-sectional study of plasma Axl, Ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A Study of the Pediatric Nephrology Research Consortium. Lupus. 2021 August; 30(9): 1394-1404
  • Mason S, Hader C, Marlier A, Moeckel G, Cantley LG. Met activation is required for early cytoprotection after ischemic kidney injury. J Am Soc Nephrol. 2014 Feb; 25(2):329-37.
  • Koraishy FM, Silva C, Mason S, Wu D, Cantley LG. Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and promotes canonical Wnt signaling. J Biol Chem. 2014 May; 289: 14341-14350.

Locations Where I See Patients

Connecticut Children's Golisano Medical Center sign lighting during the Foundation's 100% In campaign launch.

Golisano Medical Center at Connecticut Children's – Hartford

282 Washington Street
Hartford, CT 06106
United States

Exterior view of 399 Farmington Ave in Farmington

Connecticut Children’s Specialty Care Center – Farmington (399 Farmington Ave.)

399 Farmington Avenue
Farmington, CT 06032
United States